SCHEMBL10827267

SCHEMBL10827267

[NH]C(=O)C(C(=O)OC(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 2/20 0.47
▸ ESR1 P03372 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ KIF11 P52732 1/20 0.43
▸ LMNA P02545 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40
▸ MMP8 P22894 1/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ SRD5A2 P31213 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ CES2 O00748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11687914 0.91 IDO1 (0.47) SRCESR1ESR2KIF11KMT2A
SCHEMBL11464028 0.88 SRC (0.54) SRCESR1ESR2KIF11LMNA
SCHEMBL9686394 0.85 SRC (0.61) SRCESR1ESR2KIF11LMNA
SCHEMBL11520442 0.85 IDO1 (0.48) ESR1ESR2KIF11ALDH1A1HPGD
SCHEMBL10917817 0.85 IDO1 (0.48) SRCESR1ESR2KIF11LMNA
SCHEMBL10827268 0.83 SRC (0.48) SRCESR1ESR2KIF11LMNA
SCHEMBL11076351 0.81 SRC (0.47) SRCESR1ESR2KIF11LMNA
SCHEMBL11520631 0.81 TNF (0.44) LMNAALDH1A1HPGDKMT2ACRHBP
SCHEMBL27874774 0.78 ESR1 (0.53) SRCESR1ESR2KIF11LMNA
SCHEMBL1954 0.78 ESR1 (0.53) SRCESR1ESR2KIF11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4478997-A 1-Oxadethiacepham compounds SHIONOGI & CO., LTD. (JP) 1984-10-23 — — US claimed
US-4443598-A ANTIBIOTICS AND INTERMEDIATES SHIONOGI & CO., LTD. (JP) 1984-04-17 — — US claimed
US-4604460-A ANTIBIOTICS, BACTERICIDES SHIONOGI & CO., LTD. (JP) 1986-08-05 — — US disclosed
US-4533730-A BACTERICIDES SHIONOGI & CO., LTD. (JP) 1985-08-06 — — US disclosed
EP-0060119-B1 AZETIDINONE COMPOUNDS AND THEIR PREPARATION ELI LILLY AND COMPANY (US) 1985-04-10 — — EP disclosed
US-4504659-A 1-Oxadethiacepham compounds SHIONOGI & CO., LTD. (JP) 1985-03-12 — — US disclosed
US-4500456-A AND AZETIDINONE-4-SULFINIC ACID, OR SALT THEREOF ELI LILLY AND COMPANY (US) 1985-02-19 — — US disclosed
US-4478997-A 1-Oxadethiacepham compounds SHIONOGI & CO., LTD. (JP) 1984-10-23 — — US disclosed
US-4443598-A ANTIBIOTICS AND INTERMEDIATES SHIONOGI & CO., LTD. (JP) 1984-04-17 — — US disclosed
US-4440683-A Cyclization to form cephem ring and azetidinone intermediates therefor SHIONOGI & CO., LTD. (JP) 1984-04-03 — — US disclosed
US-4368156-A USING POSITIVE HALOGEN REAGENT ELI LILLY AND COMPANY (US) 1983-01-11 — — US disclosed
US-4346218-A DECYCLIZATION OF AN AZETIDINOTHIAZOLINE SHIONOGI & CO., LTD. (JP) 1982-08-24 — — US disclosed
US-4332722-A BICYCLIC AZETIDINOTHIAZOLINES SHIONOGI & CO., LTD. (JP) 1982-06-01 — — US disclosed
US-4271305-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-06-02 — — US disclosed
US-4226986-A 7-ACYLAMINO-3-HYDROXY-3-CEPHEM COMPOUND, TRIARYL PHOSPHITE DIHALIDE ELI LILLY AND COMPANY (US) 1980-10-07 — — US disclosed
US-4223133-A USING A TRIARYL PHOSPHITE-HALOGEN COMPLEX ELI LILLY AND COMPANY (US) 1980-09-16 — — US disclosed
EP-0014567-A1 Processes for preparation of beta-lactam compounds ELI LILLY AND COMPANY (US) 1980-08-20 — — EP disclosed
US-4211702-A TRIARYLPHOSPHITE-HALOGEN COMPLEX HALOGENATING AGENT ELI LILLY AND COMPANY (US) 1980-07-08 — — US disclosed
US-4160085-A Cyclization to form cephem ring and intermediates therefor SHIONOGI & CO., LTD. (JP) 1979-07-03 — — US disclosed
US-4079181-A INTERMEDIATES FOR 3-HYDROXY-3-CEPHEM COMPOUNDS SHIONOGI & CO., LTD. (JA) 1978-03-14 — — US disclosed
Send feedback